LM2I
LM2I is a derivative of Spinosyn A (SPA) . LM2I is argininosuccinate synthase (ASS1) enzyme activator, and tumor inhibitor that directly interact with ASS1. LM2I has significant antiproliferative activity in seven colorectal cancer cell-lines and xenograft tumors of colorectal cancer. LM2I inhibits colorectal cancer cell growth via the EGFR pathway[1].
Product Specifications
CAS Number
2055494-50-1
UNSPSC
12352005
Target
Ser/Thr Protease
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lm2i.html
Purity
99.78
Solubility
DMSO : ≥ 100 mg/mL
Smiles
Molecular Formula
C47H77N3O11
Molecular Weight
860.13
References & Citations
[1]Peng K, et al. Spinosyn A and Its Derivative Inhibit Colorectal Cancer Cell Growth via the EGFR Pathway. J Nat Prod. 2023 Sep 8.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Respiratory Syncytial Virus, Fusion Protein 1c (RSV) (MaxLight 750) discontinued
N- (3-Hydroxy-2- (4- (4-Methyl-1,4-Diazepan-1-Yl) Benzamido) Phenyl) -4-Methoxybenzamide
N- (3-Hydroxy-2- (4- (4-Methyl-1,4-Diazepan-1-Yl) Benzamido) Phenyl) -4-Methoxybenzamide